Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Before you respond

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Bids
  3. ›Federal
  4. ›NIH Brain Development Cohorts (NBDC) and�Population…

U.S. National Institutes of Health·United States of America

NIH Brain Development Cohorts (NBDC) and�Population Assessment of Tobacco and Health (PATH) Study�Biospecimen Access (X01 Clinical Trial Not Allowed)

Closes 4/17/2029$100k – $500kGrants Notice
Get bids like this by emailBid source

Description

The National Institutes of Health (NIH) is offering the scientific community access to limited biospecimens collected under three major longitudinal studies – the Adolescent Brain Cognitive Development (ABCD) Study, the HEALthy Brain and Child Development (HBCD) Study, and the Population Assessment of Tobacco and Health (PATH) Study. Applicants may request these samples to conduct secondary research that aligns with the original study objectives and advances understanding of genetic, environmental, and substance‑exposure factors affecting health across the lifespan. The opportunity is funded as a grant (X01) – no clinical trial is allowed, cost‑sharing is not required, and foreign sub‑awards are prohibited. Eligibility is broad, covering nonprofit, for‑profit, governmental, tribal, and other entities, both domestic and foreign (as long as no sub‑awards are involved). The award ceiling and floor are “none,” indicating no set funding limit per award. Applications are due by April 17 2029, with the award expected in January 2027. • Access to biospecimens from ABCD, HBCD, and PATH cohorts • Research must be consistent with original study aims and NIH health priorities • Open to a wide range of U.S. and foreign organizations (no sub‑awards) • No cost‑sharing required; funding amount not pre‑specified • Application deadline: 04/17/2029; anticipated award date: 01/04/2027 • Primary contact: NBDC Biospecimen Team ([email protected])

Attached files

Contact

NBDC Biospecimen Team(Scientific/Research Contact)

[email protected]

(301) 402-2541

Key dates

Opened
9/10/2025
Closes
4/17/2029
Projected award
1/4/2027
Duration
4 years

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541715
Solicitation №
PAR-27-051

Budget estimate

$100,000 – $500,000

NIH does not publish a fixed award ceiling for this X01 biospecimen‑access grant, but similar NIH supplemental research grants for secondary data or biospecimen use typically range from $100,000 to $500,000 per award, depending on the scope of sample acquisition, data analysis, and personnel costs. The estimate assumes a modest‑size research team (1‑2 investigators, a post‑doc or data analyst) and a 1‑2 year project to process and analyze the specimens. Larger multi‑institution collaborations could push the upper bound higher, while single‑investigator projects could be nearer the lower bound.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one. Bid Banana has 1.6M+ bids and awards.

You found this bid by looking. Bid Banana searches open government bids across all 50 states, updated daily, so you stop hunting: save a search once and we email you your new matches, daily or weekly.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 86%

Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed)

Closes 3/1/2027Opened 1/8/2026

U.S. National Institutes of Health·United States of America

85% match

Development of Models, New Approach Methodologies, and Biological Materials for Studying Human Health and Diseases (R21 Clinical Trial Not Allowed)

Closes 2/15/2028Opened 9/16/2026

U.S. National Institutes of Health·United States of America

85% match

National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)

Closes 1/24/2027Opened 6/9/2026

U.S. National Institutes of Health·United States of America

85% match

Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)

Closes 2/11/2027Opened 1/13/2026

U.S. National Institutes of Health·United States of America

85% match

NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 12/18/2024

U.S. National Institutes of Health·United States of America

84% match

National Biomedical Research Centers (P50 Clinical Trial Optional)

Closes 1/24/2027Opened 5/12/2026

U.S. National Institutes of Health·United States of America

84% match

Research Experiences and/or Mentoring Networks through Research Education to Enhance Clinician-Scientists' Participation in NIDCDs Research (R25 Clinical Trial Not Allowed)

Closes 9/29/2027Opened 10/2/2024

U.S. National Institutes of Health·United States of America

84% match

BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)

Closes 1/28/2027Opened 3/19/2024

U.S. National Institutes of Health·United States of America

84% match

NINDS Efficacy and Exploratory Clinical Trials (UG3/UH3 - Clinical Trial Required)

Closes 3/9/2029Opened 8/28/2025

U.S. National Institutes of Health·United States of America

84% match

Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)

Closes 7/5/2029Opened 9/9/2025

U.S. National Institutes of Health·United States of America

84% match

Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)

Closes 6/16/2028Opened 3/16/2026

U.S. National Institutes of Health·United States of America

84% match

Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional)

Closes 10/11/2029Opened 3/10/2026

U.S. National Institutes of Health·United States of America

84% match

NIH Research Program Projects (Parent P01 Clinical Trial Optional)

Closes 5/25/2029Opened 2/11/2026

U.S. National Institutes of Health·United States of America

84% match

Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) Infrastructure ? Clinical Research Sites (U24 Clinical Trial Not Allowed)

Closes 10/31/2027Opened 9/10/2026

U.S. National Institutes of Health·United States of America

84% match

NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)

Closes 9/7/2027Opened 3/7/2024

U.S. National Institutes of Health·United States of America

84% match

NIH Research Education Program - Research Experiences (Parent R25 - Clinical Trial Not Allowed)

Closes 5/5/2029Opened 1/15/2026

U.S. National Institutes of Health·United States of America

84% match

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 1/11/2022

U.S. National Institutes of Health·United States of America

84% match

BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed)

Closes 2/8/2029Opened 8/28/2025

U.S. National Institutes of Health·United States of America

83% match

NICHD Resource Program Grants in Bioinformatics (P41 Clinical Trial Not Allowed)

Closes 9/25/2027Opened 9/24/2024

U.S. National Institutes of Health·United States of America

83% match

NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 5/5/2020

U.S. National Institutes of Health·United States of America

83% match

Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

Closes 8/18/2027Opened 10/1/2024

U.S. National Institutes of Health·United States of America

83% match

NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)

Closes 11/13/2026Opened 1/3/2024

U.S. National Institutes of Health·United States of America

83% match

NIH Research Project Grant (Parent R01 Clinical Trial Required)

Closes 1/7/2028Opened 12/18/2024

U.S. National Institutes of Health·United States of America

83% match

Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

Closes 5/24/2027Opened 9/23/2026

U.S. National Institutes of Health·United States of America

83% match

BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System

Closes 1/27/2027Opened 9/10/2026